[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Liver;
DOI=10.1021/bi00459a034; PubMed=1691923 [NCBI, ExPASy, EBI, Israel, Japan]
Jaiswal A.K.,
Burnett P.,
Adesnik M.,
McBride O.W.;
"Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.";
Biochemistry 29:1899-1906(1990).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
TISSUE=Liver;
PubMed=8182056 [NCBI, ExPASy, EBI, Israel, Japan]
Jaiswal A.K.;
"Human NAD(P)H:quinone oxidoreductase 2. Gene structure, activity, and tissue-specific expression.";
J. Biol. Chem. 269:14502-14508(1994).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
Iida A.,
Osawa S.,
Kitamura Y.,
Kitamoto T.,
Koyama K.,
Nakamura Y.;
"Human NRH:quinone oxidoreductase 2, complete genomic sequence.";
Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-16; GLY-29; LEU-47; ASP-58 AND ALA-184.
Livingston R.J.,
Rieder M.J.,
Chung M.-W.,
Ritchie T.K.,
Olson A.N.,
Nguyen C.P.,
Gildersleeve H.,
Cassidy C.M.,
Johnson E.J.,
Swanson J.E.,
McFarland I.,
Yool B.,
Park C.,
Nickerson D.A.;
"NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).";
Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
|
[5]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[6]
|
CHARACTERIZATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
DOI=10.1006/abbi.1997.0344; PubMed=9367528 [NCBI, ExPASy, EBI, Israel, Japan]
Wu K.,
Knox R.,
Sun X.Z.,
Joseph P.,
Jaiswal A.K.,
Zhang D.,
Deng P.S.-K.,
Chen S.;
"Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.";
Arch. Biochem. Biophys. 347:221-228(1997).
|
[7]
|
CHARACTERIZATION.
DOI=10.1073/pnas.94.5.1669; PubMed=9050836 [NCBI, ExPASy, EBI, Israel, Japan]
Zhao Q.,
Yang X.L.,
Holtzclaw W.D.,
Talalay P.;
"Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).";
Proc. Natl. Acad. Sci. U.S.A. 94:1669-1674(1997).
|
[8]
|
ERRATUM.
Zhao Q.,
Yang X.L.,
Holtzclaw W.D.,
Talalay P.;
Proc. Natl. Acad. Sci. U.S.A. 94:5979-5979(1997).
|
[9]
|
BIOPHYSICOCHEMICAL PROPERTIES.
DOI=10.1021/bi035923w; PubMed=15078100 [NCBI, ExPASy, EBI, Israel, Japan]
Kwiek J.J.,
Haystead T.A.J.,
Rudolph J.;
"Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.";
Biochemistry 43:4538-4547(2004).
|
[10]
|
X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
DOI=10.1021/bi990799v; PubMed=10433694 [NCBI, ExPASy, EBI, Israel, Japan]
Foster C.E.,
Bianchet M.A.,
Talalay P.,
Zhao Q.,
Amzel L.M.;
"Crystal structure of human quinone reductase type 2, a metalloflavoprotein.";
Biochemistry 38:9881-9886(1999).
|
[11]
|
X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEX WITH RESVERATROL.
DOI=10.1021/bi049162o; PubMed=15350128 [NCBI, ExPASy, EBI, Israel, Japan]
Buryanovskyy L.,
Fu Y.,
Boyd M.,
Ma Y.,
Hsieh T.-C.,
Wu J.M.,
Zhang Z.;
"Crystal structure of quinone reductase 2 in complex with resveratrol.";
Biochemistry 43:11417-11426(2004).
|
[12]
|
X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) IN COMPLEX WITH CB1954, AND MUTANT HIS-162.
DOI=10.1016/j.bbrc.2005.08.081; PubMed=16129418 [NCBI, ExPASy, EBI, Israel, Japan]
Fu Y.,
Buryanovskyy L.,
Zhang Z.;
"Crystal structure of quinone reductase 2 in complex with cancer prodrug CB1954.";
Biochem. Biophys. Res. Commun. 336:332-338(2005).
|
|
ExPASy Home page
YPRC Korea